Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 113938
Published online Aug 15, 2026. doi: 10.4239/wjd.113938
Published online Aug 15, 2026. doi: 10.4239/wjd.113938
Table 2 Multivariate analysis of variance results of blood lead levels in each group of mice
| Factors | F value | P value |
| Genotype | 0.002 | 0.964 |
| Diabetes | 23.619 | < 0.001 |
| Pb exposure | 198.072 | < 0.001 |
| Genotype × diabetes | 0.499 | 0.486 |
| Genotype × Pb | 0.006 | 0.937 |
| Diabetes × Pb | 20.556 | < 0.001 |
| Genotype × diabetes × Pb | 0.415 | 0.525 |
- Citation: Liang X, Yang LX, Tao T, Ding WJ, Tang XY, Shang ZB, Zhou H, He Y, Sun Y. Role of CCM3 in lead-induced neurological damage in diabetes. World J Diabetes 2026; 17(8): 113938
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/113938.htm
- DOI: https://dx.doi.org/10.4239/wjd.113938